A phase 2 study, aiming to evaluate the efficacy, safety and pharmacokinetics of REC 0/0559 in treatment of Neurotrophic Keratitis in Adult Patient in Europe and United States of America.
Age: 18 years - 66+
Gender: All
We've found 1 total result for "Keratitis".